BioCryst Pharmaceuticals | Capitale Di Prestito



Loan Capital Cambiamento Data
Alnylam Pharmaceuticals USD 1.03B 956K 2025-06
Chugai Pharma JPY 0 0 2025-03
Daiichi Sankyo JPY 100.84B 96M 2025-06
DBV Technologies USD 0 0 2025-03
Gilead Sciences USD 22.14B 6M 2025-06
GlaxoSmithKline GBP 15.3B 1.17B 2025-06
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Incyte USD 31.76M 883K 2025-06
Ionis Pharmaceuticals USD 625.49M 625.22M 2025-06
Neurocrine Biosciences USD 0 0 2024-12
PTC Therapeutics USD 2.13B 1.85B 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
Sarepta Therapeutics USD 1.14B 1.17M 2025-06
Ultragenyx Pharmaceutical USD 782.75M 782.75M 2025-06
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12


BioCryst Pharmaceuticals Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.